ORIGINAL RESEARCH article
Front. Hum. Neurosci.
Sec. Brain Health and Clinical Neuroscience
This article is part of the Research TopicNew horizons in stroke management: Volume IIView all 10 articles
Clinical exome sequencing identifies novel gene variants associated with ischemic stroke in the Saudi Tabuk population
Provisionally accepted- 1Medical laboratory technology, Faculty of applied medical sciences, University of Tabuk, Tabuk, Saudi Arabia
- 2Department of Biology, FAS, Genome and Biotechnology Unit, Faculty of Science, University of Tabuk, Tabuk, Saudi Arabia
- 3Clinical Laboratory Sciences Department, College of Applied Medical Sciences, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
- 4Department of Pharmacology and Toxicology, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al Kharj, Saudi Arabia
- 5Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, Hematology Research Unit (HRU), King Fahad Medical Research Center (KFMRC),, King Abdulaziz University, Jeddah, Saudi Arabia
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Variants linked to the risk of ischaemic stroke have been discovered through genome-wide association studies (GWASs). These variations frequently have little consequences that lack apparent biological significance. Hence, these findings demonstrate that exome sequencing can be highly relevant to stroke, even though stroke is a complex phenotype with various diseases and risk factors. Methodology: In this case-control investigation, we used ARMS genotyping to investigate the distribution of polymorphic variations in genes associated with stroke susceptibility. In addition to examine the novel gene variations associated with ischaemic stroke we utilized the Illumina NovaSeq 6000 platform for whole-exome sequencing (WES). Results: Results identified 11 novel gene variants in the GSTT4 gene by Targeted Whole-Exome Sequencing, including one deletion GSTT4p.Asn232LysfsTer6, one insertion c.688_689insCG, and 9 SNVs c.699T>C, c.701C>G, c.708G>T, c.710T>G, c.712A>G, c.712A>G, c.718A>T, c.719G>A, c.721A>T, c.722G>T in the ischaemic stroke patients. We also identified several rare, intermediate, and most common gene variants in cholesterol associated genes LDLR, LDLRAD2, LDLRAD3, APOA2, APOA3, APOA4, APOA5, and PCSK9. Also, several common gene variants were reported in MTHFR, KLF14, eNOS3, and ACE by whole-exome sequencing. Furthermore, the eNOS3-GG and eNOS3-GT genotypes were associated with susceptibility to ischaemic stroke (OR=1.95, P<0.05). Conclusion: This case-control study identified eleven novel GSTT4 variants and several known polymorphisms associated with ischemic stroke risk in Saudi patients. These findings highlight population-specific genetic factors that warrant further functional and large-scale validation.
Keywords: ischaemic stroke, Targeted Whole-Exome Sequencing, gene polymorphisms, Personalised medicine, MTHFR, KLF-14, eNOS, ACE
Received: 12 Jun 2025; Accepted: 12 Dec 2025.
Copyright: © 2025 Hamadi, Mir, Alamer, Alasseiri, AlZamzami, Alatawi, Alanazi, Oyouni, Al Tuwaijri, Althenayyan, Madkhali, Alserihi and Moawadh. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Abdullah Hamadi
Rashid Mir
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
